BCL6B, BCL6B transcription repressor, 255877

N. diseases: 16; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.040 AlteredExpression disease BEFREE Finally, significant negative correlations were detected between the mRNA levels of BCL6B and inflammatory cytokines in human GC tissues; patients harbouring BCL6B-negetive and severe-inflammation GC tumours were found to exhibit the shortest survival time. 31288844 2019
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.040 PosttranslationalModification disease BEFREE Here, we quantitatively detect the methylated status of CpG sites of BCL6B DNA promoter of 459 patients with gastric cancer (GC) by using bisulfite gene sequencing. 25008234 2014
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.040 Biomarker disease BEFREE BCL6B methylation may serve as a novel potential non-invasive plasma biomarker for the detection of gastric cancer. 24191714 2013
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.040 AlteredExpression disease BEFREE Re-expression of BCL6B in GC cell lines inhibited colony formation, suppressed cell viability, induced apoptosis and restrained the tumorigenecity in nude mice. 21917650 2012